• Science & Technology
• Health & Medicine

2023 roundup: 5 of our most important cancer research stories of the year

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

18 December 2023

• Health & Medicine

Decline in smoking rates stalled during the pandemic, new study reveals

The decline in smoking prevalence in England has nearly ground to a halt since the start of the pandemic, according to a new study The decline in smoking prevalence in England has nearly ground to a halt since the start of the pandemic, according to a new study

14 December 2023

• For Researchers

MOv18 - opening a new front for immunotherapy

Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug... Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug...

12 December 2023

• Health & Medicine

PFAS and cancer: what do we know about forever chemicals?

The International Agency for Research on Cancer has evaluated the risks of two types of forever chemical. Here's what the evidence tells us. The International Agency for Research on Cancer has evaluated the risks of two types of forever chemical. Here's what the evidence tells us.

11 December 2023

• Health & Medicine

Lung cancer screening could save thousands of lives in Scotland, Wales and Northern Ireland

Introducing lung cancer screening programmes in Scotland, Wales and Northern Ireland could help thousands more people get an early diagnosis. Introducing lung cancer screening programmes in Scotland, Wales and Northern Ireland could help thousands more people get an early diagnosis.

5 December 2023

• Health & Medicine

Durvalumab immunotherapy recommended for advanced bile duct cancers in England and Scotland

The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland. The immunotherapy durvalumab (Imfinzi) is now available as a first treatment for advanced biliary tract cancers in England and Scotland.

30 November 2023

• Charity News

Highlights from our first Children’s and Young People’s Cancer Research Conference

Cancer Research UK held its first Children’s and Young People’s Cancer Research Conference at the Royal Society in London, with researchers, students and funders. Cancer Research UK held its first Children’s and Young People’s Cancer Research Conference at the Royal Society in London, with researchers, students and funders.

29 November 2023

• For Researchers

How the next Government can transform cancer research

We have spent 2023 developing a comprehensive view of the policy changes needed to improve cancer research and care We have spent 2023 developing a comprehensive view of the policy changes needed to improve cancer research and care

28 November 2023

• Policy & Insight
• Charity News

Cancer Research UK launches ambitious manifesto to avoid 20,000 cancer deaths a year by 2040

Cancer Research UK has today published an ambitious manifesto setting out how the next UK Government could dramatically improve cancer outcomes and prevent 20,000 cancer deaths a year by 2040.   Cancer Research UK has today published an ambitious manifesto setting out how the next UK Government could dramatically improve cancer outcomes and prevent 20,000 cancer deaths a year by 2040.  

28 November 2023